drugset

Drugs / Rb-82

Follow last change Jul 2018 re-read 2 minutes ago

Rb-82

also known as Rubidium

Diagnostic / imaging agent

Investigated by: Yale University

Trials 1 · a red edge is where a trial was stopped

today NCT03048097 · Ph 0

2017201820192020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 0	NCT03048097	Feb 2017 → Jul 2018	sarcoidosis	Yale University	Completed	No outcome recorded

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT00808314 Comparator	Dec 2008 → Dec 2010	coronary artery disorder	Cardiovascular Imaging Technologies	Unknown	No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Rb-82	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00808314 ↗
Known as	Rubidium	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03048097 ↗
Modality	Diagnostic / imaging agent	“Lexiscan(TM) Rb-82 Myocardial Perfusion PET” NCT00808314 ↗
Route	Other	“approximately 60 mCi of Rb-82 will be infused” NCT00808314 ↗